24513321|t|Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasis.
24513321|a|The neurotoxicity of amyloid beta (Abeta), a major cleavage product of the amyloid precursor protein (APP), is enhanced by iron, as found in the amyloid plaques of Alzheimer's disease (AD) patients. By contrast, the long-known neuroprotective activity of APP is evident after alpha-secretase cleavage of the precursor to release sAPPalpha, and depends on the iron export actions of APP itself. The latter underlie its neurotrophic and protective effects in facilitating the homeostatic actions of ferroportin mediated-iron export. Thus APP-dependent iron export may alleviate oxidative stress by minimizing labile iron thus protecting neurons from iron overload during stroke and hemorrhage. Consistent with this, altered phosphorylation of iron-regulatory protein-1 (IRP1) and its signaling processes play a critical role in modulating APP translation via the 5' untranslated region (5'UTR) of its transcript. The APP 5'UTR region encodes a functional iron-responsive element (IRE) RNA stem loop that represents a potential target for modulating APP production. Targeted regulation of APP gene expression via the modulation of 5'UTR sequence function represents a novel approach for the potential treatment of AD since altering APP translation can be used to improve both the protective brain iron balance and provide anti-amyloid efficacy. Approved drugs including paroxetine and desferrioxamine and several novel compounds have been identified that suppress abnormal metal-promoted Abeta accumulation with a subset of these acting via APP 5'UTR-dependent mechanisms to modulate APP translation and cleavage to generate the non-toxic sAPPalpha. 
24513321	0	19	Alzheimer's disease	Disease	MESH:D000544
24513321	60	85	amyloid precursor protein	Gene	351
24513321	120	124	iron	Chemical	MESH:D007501
24513321	142	155	neurotoxicity	Disease	MESH:D020258
24513321	159	171	amyloid beta	Gene	351
24513321	173	178	Abeta	Gene	351
24513321	213	238	amyloid precursor protein	Gene	351
24513321	261	265	iron	Chemical	MESH:D007501
24513321	283	298	amyloid plaques	Disease	MESH:D058225
24513321	302	321	Alzheimer's disease	Disease	MESH:D000544
24513321	323	325	AD	Disease	MESH:D000544
24513321	327	335	patients	Species	9606
24513321	497	501	iron	Chemical	MESH:D007501
24513321	656	660	iron	Chemical	MESH:D007501
24513321	688	692	iron	Chemical	MESH:D007501
24513321	752	756	iron	Chemical	MESH:D007501
24513321	786	799	iron overload	Disease	MESH:D019190
24513321	807	813	stroke	Disease	MESH:D020521
24513321	818	828	hemorrhage	Disease	MESH:D006470
24513321	879	904	iron-regulatory protein-1	Gene	48
24513321	906	910	IRP1	Gene	48
24513321	1091	1095	iron	Chemical	MESH:D007501
24513321	1349	1351	AD	Disease	MESH:D000544
24513321	1432	1436	iron	Chemical	MESH:D007501
24513321	1462	1469	amyloid	Disease	MESH:C000718787
24513321	1505	1515	paroxetine	Chemical	MESH:D017374
24513321	1520	1535	desferrioxamine	Chemical	MESH:D003676
24513321	1608	1613	metal	Chemical	MESH:D008670
24513321	1623	1628	Abeta	Gene	351
24513321	Negative_Correlation	MESH:D017374	351
24513321	Association	MESH:D000544	351
24513321	Positive_Correlation	MESH:D007501	351
24513321	Association	351	48
24513321	Positive_Correlation	MESH:D008670	351
24513321	Negative_Correlation	MESH:D008670	MESH:D017374
24513321	Negative_Correlation	MESH:D003676	MESH:D008670
24513321	Positive_Correlation	MESH:D007501	MESH:D020258
24513321	Negative_Correlation	MESH:D017374	MESH:D000544
24513321	Association	MESH:D007501	MESH:D020521
24513321	Association	MESH:D020258	351
24513321	Negative_Correlation	MESH:D003676	351
24513321	Association	MESH:D007501	MESH:D000544
24513321	Association	MESH:D007501	MESH:D058225

